Literature DB >> 6299497

The epidermal growth factor (EGF).

S Cohen.   

Abstract

This review summarizes briefly some of the historical aspects of the discovery, isolation, and mode of action of epidermal growth factor (EGF). Also considered are some of the key experiments which relate the biochemical mechanisms of EGF action to the mechanism involved in oncogenic transformation by the retroviruses.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6299497     DOI： 10.1002/1097-0142(19830515)51:10<1787::aid-cncr2820511004>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  45 in total

1.  Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor.

Authors:  D C Márquez; J Lee; T Lin; R J Pietras
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

Review 2.  Protein-based tumor molecular imaging probes.

Authors:  Xin Lin; Jin Xie; Xiaoyuan Chen
Journal:  Amino Acids       Date:  2010-03-17       Impact factor: 3.520

Review 3.  Epidermal growth factor receptor and bladder cancer.

Authors:  A J Colquhoun; J K Mellon
Journal:  Postgrad Med J       Date:  2002-10       Impact factor: 2.401

Review 4.  Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer.

Authors:  Naoko Matsuda; Bora Lim; Xiaoping Wang; Naoto T Ueno
Journal:  Expert Opin Investig Drugs       Date:  2017-03-08       Impact factor: 6.206

5.  Phosphorylated epidermal growth factor receptor and cyclooxygenase-2 expression in localized non-small cell lung cancer.

Authors:  Seok Jin Kim; Zahid N Rabbani; Fan Dong; Robin T Vollmer; Ernst-Gilbert Schreiber; Mark W Dewhirst; Zeljko Vujaskovic; Michael J Kelley
Journal:  Med Oncol       Date:  2009-02-24       Impact factor: 3.064

6.  The trophic effect of epidermal growth factor on morphological changes and polyamine metabolism in the small intestine of rats.

Authors:  T Tsujikawa; T Bamba; S Hosoda
Journal:  Gastroenterol Jpn       Date:  1990-06

7.  Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis.

Authors:  Ronald A Lubet; Eva Szabo; Kenneth K Iwata; Stanley C Gill; Chris Tucker; Ann Bode; Vernon E Steele; M Margaret Juliana; Holly L Nicastro; Clinton J Grubbs
Journal:  Cancer Prev Res (Phila)       Date:  2013-03-26

8.  Deconvoluting lung evolution: from phenotypes to gene regulatory networks.

Authors:  John S Torday; Virender K Rehan; James W Hicks; Tobias Wang; John Maina; Ewald R Weibel; Connie C W Hsia; Ralf J Sommer; Steven F Perry
Journal:  Integr Comp Biol       Date:  2007-07-26       Impact factor: 3.326

9.  Erlotinib treatment in pretreated patients with non-small cell lung cancer: A Phase II study.

Authors:  G P Stathopoulos; D Trafalis; J Dimitroulis; A Athanasiou; J Koutantos; A Anagnostopoulos
Journal:  Oncol Lett       Date:  2010-03-01       Impact factor: 2.967

10.  Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies.

Authors:  J P Hong; S-W Lee; S Y Song; S D Ahn; S S Shin; E K Choi; J H Kim
Journal:  Eur J Cancer Care (Engl)       Date:  2009-04-23       Impact factor: 2.520
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.